<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">567814</article-id><article-id pub-id-type="doi">10.17816/KMJ567814</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Alzheimer’s disease: risk factors, cellular and molecular basis of pathogenesis, analysis of pathogenetic mechanisms in comparison with amyotrophic lateral sclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Болезнь Альцгеймера: факторы риска, клеточно-молекулярные основы патогенеза, анализ патогенетических механизмов в сравнении с боковым амиотрофическим склерозом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-4926-3192</contrib-id><contrib-id contrib-id-type="researcherid">IXN-6934-2023</contrib-id><contrib-id contrib-id-type="spin">1497-7867</contrib-id><name-alternatives><name xml:lang="en"><surname>Akhmadieva</surname><given-names>Liaisan A.</given-names></name><name xml:lang="ru"><surname>Ахмадиева</surname><given-names>Ляйсан Айдаровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Research Fellow, Neurosciences Institute</p></bio><bio xml:lang="ru"><p>мл. науч. сотрудник, Институт нейронаук</p></bio><email>lyaisan.akhmadieva@kazangmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-1577-9780</contrib-id><contrib-id contrib-id-type="spin">1012-0178</contrib-id><name-alternatives><name xml:lang="en"><surname>Nagiev</surname><given-names>Kerim K.</given-names></name><name xml:lang="ru"><surname>Нагиев</surname><given-names>Керим Казбекович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant, Depart. of Normal Physiology</p></bio><bio xml:lang="ru"><p>асс., каф. нормальной физиологии</p></bio><email>drkerim@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7436-7815</contrib-id><contrib-id contrib-id-type="spin">6239-1965</contrib-id><name-alternatives><name xml:lang="en"><surname>Zefirov</surname><given-names>Andrey L</given-names></name><name xml:lang="ru"><surname>Зефиров</surname><given-names>Андрей Львович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Academician of RAS, Prof., Depart. of Normal Physiology</p></bio><bio xml:lang="ru"><p>д-р. мед. наук, акад. РАН, проф., каф. нормальной физиологии</p></bio><email>zefiroval@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0397-9002</contrib-id><contrib-id contrib-id-type="spin">6625-7526</contrib-id><name-alternatives><name xml:lang="en"><surname>Mukhamedyarov</surname><given-names>Marat A.</given-names></name><name xml:lang="ru"><surname>Мухамедьяров</surname><given-names>Марат Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Prof., Head of Depart., Depart. of Normal Physiology</p></bio><bio xml:lang="ru"><p>д-р. мед. наук, проф., зав. каф., каф. нормальной физиологии</p></bio><email>marat.muhamedyarov@kazangmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan State Medical University</institution></aff><aff><institution xml:lang="ru">Казанский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-07-05" publication-format="electronic"><day>05</day><month>07</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-07-25" publication-format="electronic"><day>25</day><month>07</month><year>2024</year></pub-date><volume>105</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>622</fpage><lpage>636</lpage><history><date date-type="received" iso-8601-date="2023-07-28"><day>28</day><month>07</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2024-05-07"><day>07</day><month>05</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2027-07-25"/></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/567814">https://kazanmedjournal.ru/kazanmedj/article/view/567814</self-uri><abstract xml:lang="en"><p>Alzheimer’s disease is a neurodegenerative disease characterized by progressive neurocognitive dysfunction. Today, studying the pathogenesis of this disease remains an urgent problem. The review describes the pathogenetic basis of Alzheimer’s disease, including not only extracellular deposition of amyloid plaques and intracellular hyperphosphorylation of tau protein with subsequent formation of neurofibrillary tangles, but also mitochondrial dysfunction, impaired autophagy, neuroinflammation, etc. Data are presented on the effect of hyperphosphorylated tau protein on the breakdown and enhancement of β-amyloid peptide synthesis. Oligomerized tau protein causes proteasomal dysfunction and oxidative stress. Mitochondrial dysfunction is closely related to oxidative stress, which can be both a cause and a consequence. Autophagy, namely mitophagy, in turn, also plays an important role in the development of mitochondrial dysfunction. It can be argued that neuroinflammation is associated with all of the listed links in pathogenesis. This review also examines the influence of intestinal dysbiosis on the development of the disease. The complex mutual influence of pathogenetic mechanisms forms a multicomponent network of pathological processes. Understanding the Alzheimer’s disease pathogenesis is necessary in the search for methods for correcting impaired functioning mechanisms of the nervous system, which will help develop effective methods for treating this disease. In addition, to better understand the mechanisms of Alzheimer’s disease development, it is necessary to search for common pathogenetic factors with other neurodegenerative diseases.</p></abstract><trans-abstract xml:lang="ru"><p>Болезнь Альцгеймера — нейродегенеративное заболевание, характеризующееся прогрессирующей нейрокогнитивной дисфункцией. На сегодняшний день изучение патогенеза данного заболевания остаётся актуальной проблемой. В обзоре описаны патогенетические основы болезни Альцгеймера, включающие не только внеклеточное отложение амилоидных бляшек и внутриклеточное гиперфосфорилирование тау-белка с последующим образованием нейрофибриллярных клубков, но и митохондриальную дисфункцию, нарушенную аутофагию, нейровоспаление и др. Приведены данные о влиянии гиперфосфорилированного тау-белка на расщепление и усиление синтеза β-амилоидного пептида. Олигомеризованный тау-белок вызывает протеасомную дисфункцию и окислительный стресс. Дисфункция митохондрий тесно связана с окислительным стрессом, который может быть как причиной, так и её следствием. Аутофагия, а именно митофагия, в свою очередь, также играет важную роль в развитии митохондриальной дисфункции. Можно утверждать, что нейровоспаление связано со всеми перечисленными звеньями патогенеза. В представленном обзоре также рассмотрено влияние дисбиоза кишечника на развитие заболевания. Сложное взаимовлияние патогенетических механизмов образует многокомпонентную сеть патологических процессов. Понимание патогенеза болезни Альцгеймера необходимо в поиске методов коррекции нарушенных механизмов функционирования нервной системы, что поможет разработать эффективные способы терапии данного недуга. Кроме того, для лучшего понимания механизмов развития болезни Альцгеймера следует проводить поиск общих патогенетических факторов с другими нейродегенеративными заболеваниями.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Alzheimer’s disease</kwd><kwd>β-amyloid peptide</kwd><kwd>tauopathy</kwd><kwd>mitochondrial dysfunction</kwd><kwd>neuroinflammation</kwd><kwd>intestinal dysbiosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>болезнь Альцгеймера</kwd><kwd>β-амилоидный пептид</kwd><kwd>таупатия</kwd><kwd>митохондриальная дисфункция</kwd><kwd>нейровоспаление</kwd><kwd>дисбиоз кишечника</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Грант Российского научного фонда</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian Science Foundation</institution></institution-wrap></funding-source><award-id>23-15-00438</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Rostagno AA. Pathogenesis of Alzheimer’s disease. Int J Mol Sci. 2022;24:107. doi: 10.3390/ijms24010107</mixed-citation><mixed-citation xml:lang="ru">Rostagno A.A. Pathogenesis of Alzheimer’s disease // Int J Mol Sci. 2022. Vol. 24. P. 107. doi: 10.3390/ijms24010107</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">September 21 is World Alzheimer's Day. Department of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare for the Volgograd Region. Available from: http://34.rospotrebnadzor.ru/ Accessed: Sep 21, 2023. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">21 сентября — Всемирный день болезни Альцгеймера. Управление федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека по Волгоградской области. Режим доступа: http://34.rospotrebnadzor.ru/ Дата обращения: 21.09.2023.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, Łos MJ. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49. doi: 10.1016/j.pneurobio.2013.10.004</mixed-citation><mixed-citation xml:lang="ru">Ghavami S., Shojaei S., Yeganeh B., et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders // Prog Neurobiol. 2014. Vol. 112. P. 24–49. doi: 10.1016/j.pneurobio.2013.10.004</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Bekris LM, Yu C-E, Bird TD, Tsuang DW. Review article: Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23:213–227. doi: 10.1177/0891988710383571</mixed-citation><mixed-citation xml:lang="ru">Bekris L.M., Yu C.-E., Bird T.D., Tsuang D.W. Review article: Genetics of Alzheimer disease // J Geriatr Psychiatry Neurol. 2010. Vol. 23. P. 213–227. doi: 10.1177/0891988710383571</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Eshraghi M, Adlimoghaddam A, Mahmoodzadeh A, Sharifzad F, Yasavoli-Sharahi H, Lorzadeh S, Albensi BC, Ghavami S. Alzheimer’s Disease pathogenesis: Role of autophagy and mitophagy focusing in microglia. Int J Mol Sci. 2021;22:3330. doi: 10.3390/ijms22073330</mixed-citation><mixed-citation xml:lang="ru">Eshraghi M., Adlimoghaddam A., Mahmoodzadeh A., et al. Alzheimer’s disease pathogenesis: Role of autophagy and mitophagy focusing in microglia // Int J Mol Sci. 2021. Vol. 22. P. 3330. doi: 10.3390/ijms22073330</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Laurent C, Buée L, Blum D. Tau and neuroinflammation: What impact for Alzheimer’s disease and tauopathies? Biomed J. 2018;41:21–33. doi: 10.1016/j.bj.2018.01.003</mixed-citation><mixed-citation xml:lang="ru">Laurent C., Buée L., Blum D. Tau and neuroinflammation: What impact for Alzheimer’s disease and tauopathies? // Biomed J. 2018. Vol. 41. P. 21–33. doi: 10.1016/j.bj.2018.01.003</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Arnsten AFT, Datta D, Del Tredici K, Braak H. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer’s disease. Alzheimers Dement. 2021;17:115–124. doi: 10.1002/alz.12192</mixed-citation><mixed-citation xml:lang="ru">Arnsten A.F.T., Datta D., Del Tredici K., Braak H. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer’s disease // Alzheimers Dement. 2021. Vol. 17. P. 115–124. doi: 10.1002/alz.12192</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Kumar A, Sidhu J, Goyal A, Tsao JW. Alzheimer Disease. Treasure Island (FL): StatPearls Publishing, 2023. р. 2.</mixed-citation><mixed-citation xml:lang="ru">Kumar A., Sidhu J., Goyal A., Tsao J.W. Alzheimer disease. Treasure Island (FL): StatPearls Publishing, 2023. P. 2.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med. 2012;2:a006148–a006148. doi: 10.1101/cshperspect.a006148</mixed-citation><mixed-citation xml:lang="ru">Tarawneh R., Holtzman D.M. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment // Cold Spring Harb Perspect Med. 2012. Vol. 2. P. a006148–a006148. doi: 10.1101/cshperspect.a006148</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Vidal C, Zhang L. An analysis of the neurological and molecular alterations underlying the pathogenesis of Alzheimer’s disease. Cells. 2021;10:546. doi: 10.3390/cells10030546</mixed-citation><mixed-citation xml:lang="ru">Vidal C., Zhang L. An analysis of the neurological and molecular alterations underlying the pathogenesis of Alzheimer’s disease // Cells. 2021. Vol. 10. P. 546. doi: 10.3390/cells10030546</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics. Int J Nanomed. 2019;14:5541–5554. doi: 10.2147/IJN.S200490</mixed-citation><mixed-citation xml:lang="ru">Tiwari S., Atluri V., Kaushik A., et al. Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics // Int J Nanomed. 2019. Vol. 14. P. 5541–5554. doi: 10.2147/IJN.S200490</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Kerr JS, Adriaanse BA, Greig NH, Mattson MP, Cader MZ, Bohr VA, Fang EF. Mitophagy and Alzheimer’s disease: Cellular and molecular mechanisms. Trends Neurosci. 2017;40:151–166. doi: 10.1016/j.tins.2017.01.002</mixed-citation><mixed-citation xml:lang="ru">Kerr J.S., Adriaanse B.A., Greig N.H., et al. Mitophagy and Alzheimer’s disease: Cellular and molecular mechanisms // Trends Neurosci. 2017. Vol. 40. P. 151–166. doi: 10.1016/j.tins.2017.01.002</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. doi: 10.1126/science.8346443</mixed-citation><mixed-citation xml:lang="ru">Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families // Science. 1993. Vol. 261. P. 921–923. doi: 10.1126/science.8346443</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Xia X, Jiang Q, McDermott J, Han J-DJ. Aging and Alzheimer’s disease: Comparison and associations from molecular to system level. Aging Cell. 2018;17:e12802. doi: 10.1111/acel.12802</mixed-citation><mixed-citation xml:lang="ru">Xia X., Jiang Q., McDermott J., Han J.-D.J. Aging and Alzheimer’s disease: Comparison and associations from molecular to system level // Aging Cell. 2018. Vol. 17. P. e12802. doi: 10.1111/acel.12802</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, Bush AI. An anemia of Alzheimer’s disease. Mol Psychiatry. 2014;19:1227–1234. doi: 10.1038/mp.2013.178</mixed-citation><mixed-citation xml:lang="ru">Faux N.G., Rembach A., Wiley J., et al. An anemia of Alzheimer’s disease // Mol Psychiatry. 2014. Vol. 19. P. 1227–1234. doi: 10.1038/mp.2013.178</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Musiek ES, Holtzman DM. Three dimensions of the amyloid hypothesis: Time, space and “wingmen”. Nature Neurosci. 2015;18:800–806. doi: 10.1038/nn.4018</mixed-citation><mixed-citation xml:lang="ru">Musiek E.S., Holtzman D.M. Three dimensions of the amyloid hypothesis: Time, space and “wingmen” // Nature Neurosci. 2015. Vol. 18. P. 800–806. doi: 10.1038/nn.4018</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Sideris D, Danial J, Emin D, Ruggeri F, Xia Z, Zhang YP, Lobanova E, Dakin H, De S, Miller A, Sang JC, Knowles TPJ, Vendruscolo M, Fraser G, Crowther D, Klenerman D. Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer’s disease. Brain Commun. 2021;3:fcab147. doi: 10.1093/braincomms/fcab147</mixed-citation><mixed-citation xml:lang="ru">Sideris D., Danial J., Emin D., et al. Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer’s disease // Brain Commun. 2021. Vol. 3. Р. fcab147. doi: 10.1093/braincomms/fcab147</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Takuma H, Tomiyama T, Kuida K, Mori H. Amyloid β peptide-induced cerebral neuronal loss is mediated by caspase-3 in vivo. J Neuropathol Exp Neurol. 2004;63:255–261. doi: 10.1093/jnen/63.3.255</mixed-citation><mixed-citation xml:lang="ru">Takuma H., Tomiyama T., Kuida K., Mori H. Amyloid β peptide-induced cerebral neuronal loss is mediated by caspase-3 in vivo // J Neuropathol Exp Neurol. 2004. Vol. 63. P. 255–261. doi: 10.1093/jnen/63.3.255</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Selkoe DJ. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer‘s disease. Annu Rev Cell Biol. 1994;10(1):373–403. doi: 10.1146/annurev.cb.10.110194.002105</mixed-citation><mixed-citation xml:lang="ru">Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer‘s disease // Annu Rev Cell Biol. 1994. Vol. 10. P. 373–403. doi: 10.1146/annurev.cb.10.110194.002105</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, Bourgeois A, Lauritzen I, Eysert F, Kinoshita PF, Cazareth J, Badot C, Fragaki K, Bussiere R, Martin C, Mary R, Bauer C, Pagnotta S, Paquis-Flucklinger V, Buée-Scherrer V, Buée L, Lacas-Gervais S, Checler F, Chami M. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains. Acta Neuropathol. 2021;141:39–65. doi: 10.1007/s00401-020-02234-7</mixed-citation><mixed-citation xml:lang="ru">Vaillant-Beuchot L., Mary A., Pardossi-Piquard R., et al. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains // Acta Neuropathol. 2021. Vol. 141. P. 39–65. doi: 10.1007/s00401-020-02234-7</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Hampel H, Vassar R, Strooper BD, Hardy J, Willem M, Singh N, Zhou J, Yan R, Vanmechelen E, De Vos A, Nisticò R, Corbo M, Imbimbo BP, Streffer J, Voytyuk I, Timmers M, Monfared AAT, Irizarry M, Albala B, Koyama A, Watanabe N, Kimura T, Yarenis L, Lista S, Kramer L, Vergallo A. The β-secretase BACE1 in Alzheimer’s disease. Biol Psychiatry. 2021;89:745–756. doi: 10.1016/j.biopsych.2020.02.001</mixed-citation><mixed-citation xml:lang="ru">Hampel H., Vassar R., Strooper B.D., et al. The β-secretase BACE1 in Alzheimer’s disease // Biol Psychiatry. 2021. Vol. 89. P. 745–756. doi: 10.1016/j.biopsych.2020.02.001</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Wang Z, Xu Q, Cai F, Liu X, Wu Y, Song W. BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis. JCI Insight. 2019;4:е123431. doi: 10.1172/jci.insight.123431</mixed-citation><mixed-citation xml:lang="ru">Wang Z., Xu Q., Cai F., et al. BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis // JCI Insight. 2019. Vol. 4. Р. е123431. doi: 10.1172/jci.insight.123431</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Li P, Marshall L, Oh G, Jakubowski JL, Groot D, He Y, Wang T, Petronis A, Labrie V. Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms. Nature Commun. 2019;10:2246. doi: 10.1038/s41467-019-10101-7</mixed-citation><mixed-citation xml:lang="ru">Li P., Marshall L., Oh G., et al. Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms // Nature Commun. 2019. Vol. 10. P. 2246. doi: 10.1038/s41467-019-10101-7</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Sharma A, Chunduri A, Gopu A, Shatrowsky C, Crusio WE, Delprato A. Common genetic signatures of Alzheimer’s disease in Down syndrome. F1000Res. 2021;9:1299. doi: 10.12688/f1000research.27096.2</mixed-citation><mixed-citation xml:lang="ru">Sharma A., Chunduri A., Gopu A., et al. Common genetic signatures of Alzheimer’s disease in Down syndrome // F1000Res. 2021. Vol. 9. P. 1299. doi: 10.12688/f1000research.27096.2</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Wolfe MS. Structure and function of the γ-secretase complex. Biochemistry. 2019;58:2953–2966. doi: 10.1021/acs.biochem.9b00401</mixed-citation><mixed-citation xml:lang="ru">Wolfe M.S. Structure and function of the γ-secretase complex // Biochemistry. 2019. Vol. 58. P. 2953–2966. doi: 10.1021/acs.biochem.9b00401</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">D‘Errico P, Meyer-Luehmann M. Mechanisms of pathogenic Tau and Aβ protein spreading in Alzheimer’s disease. Front Aging Neurosci. 2020;12:265. doi: 10.3389/fnagi.2020.00265</mixed-citation><mixed-citation xml:lang="ru">D‘Errico P., Meyer-Luehmann M. Mechanisms of pathogenic Tau and Aβ protein spreading in Alzheimer’s disease // Front Aging Neurosci. 2020. Vol. 12. P. 265. doi: 10.3389/fnagi.2020.00265</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Jiang L, Dong H, Cao H, Ji X, Luan S, Liu J. Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer’s disease. Med Sci Monit. 2019;25:3329–3335. doi: 10.12659/MSM.914027</mixed-citation><mixed-citation xml:lang="ru">Jiang L., Dong H., Cao H., et al. Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer’s disease // Med Sci Monit. 2019. Vol. 25. P. 3329–3335. doi: 10.12659/MSM.914027</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Arnsten AFT, Datta D, Leslie S, Yang ST, Wang M, Nairn AC. Alzheimer's-like pathology in aging rhesus macaques: unique opportunity to study the etiology and treatment of Alzheimer's disease. Proc Natl Acad Sci U S A. 2019;116:26230–26238. doi: 10.1073/pnas.1903671116</mixed-citation><mixed-citation xml:lang="ru">Arnsten A.F.T., Datta D., Leslie S., et al. Alzheimer's-like pathology in aging rhesus macaques: Unique opportunity to study the etiology and treatment of Alzheimer's disease // Proc Natl Acad Sci U S A. 2019. Vol. 116. P. 26230–26238. doi: 10.1073/pnas.1903671116</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Wang Y, Balaji V, Kaniyappan S, Krüger L, Irsen S, Tepper K, Chandupatla R, Maetzler W, Schneider A, Mandelkow E, Mandelkow E. The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener. 2017;12:5. doi: 10.1186/s13024-016-0143-y</mixed-citation><mixed-citation xml:lang="ru">Wang Y., Balaji V., Kaniyappan S., et al. The release and trans-synaptic transmission of Tau via exosomes // Mol Neurodegener. 2017. Vol. 12. Р. 5. doi: 10.1186/s13024-016-0143-y</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Fiandaca M, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 2015;11:600. doi: 10.1016/j.jalz.2014.06.008</mixed-citation><mixed-citation xml:lang="ru">Fiandaca M., Kapogiannis D., Mapstone M., et al. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study // Alzheimers Dement. 2015. Vol. 11. P. 600. doi: 10.1016/j.jalz.2014.06.008</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s disease. J Cell Biol. 2018;217:459–472. doi: 10.1083/jcb.201709069</mixed-citation><mixed-citation xml:lang="ru">Hansen D.V., Hanson J.E., Sheng M. Microglia in Alzheimer’s disease // J Cell Biol. 2018. Vol. 217. P. 459–472. doi: 10.1083/jcb.201709069</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Ren Q-G, Liao X-M, Chen X-Q, Liu G-P, Wang J-Z. Effects of tau phosphorylation on proteasome activity. FEBS Lett. 2007;581:1521–1528. doi: 10.1016/j.febslet.2007.02.065</mixed-citation><mixed-citation xml:lang="ru">Ren Q.-G., Liao X.-M., Chen X.-Q., et al. Effects of tau phosphorylation on proteasome activity // FEBS Lett. 2007. Vol. 581. P. 1521–1528. doi: 10.1016/j.febslet.2007.02.065</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, Schilling B, Mavros C, Masters CL, Volitakis I, Li Q, Laughton K, Hubbard A, Cherny RA, Gibson B, Bush AI. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One. 2007;2:e536. doi: 10.1371/journal.pone.0000536</mixed-citation><mixed-citation xml:lang="ru">Melov S., Adlard P.A., Morten K., et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau // PLoS One. 2007. Vol. 2. P. e536. doi: 10.1371/journal.pone.0000536</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Cadonic C, Sabbir MG, Albensi BC. Mechanisms of mitochondrial dysfunction in Alzheimer’s disease. Mol Neurobiol. 2016;53:6078–6090. doi: 10.1007/s12035-015-9515-5</mixed-citation><mixed-citation xml:lang="ru">Cadonic C., Sabbir M.G., Albensi B.C. Mechanisms of mitochondrial dysfunction in Alzheimer’s disease // Mol Neurobiol. 2016. Vol. 53. P. 6078–6090. doi: 10.1007/s12035-015-9515-5</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Chen JX, Du YS. Amyloid-β-induced mitochondrial dysfunction. J Alzheimers Dis. 2007;12:177–184. doi: 10.3233/JAD-2007-12208</mixed-citation><mixed-citation xml:lang="ru">Chen J.X., Du Y.S. Amyloid-β-induced mitochondrial dysfunction // J Alzheimers Dis. 2007. Vol. 12. P. 177–184. doi: 10.3233/JAD-2007-12208</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Chen G, Xu T, Yan Y, Zhou Y, Jiang Y, Melcher K, Xu HE. Amyloid beta: Structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38:1205–1235. doi: 10.1038/aps.2017.28</mixed-citation><mixed-citation xml:lang="ru">Chen G., Xu T., Yan Y., et al. Amyloid beta: Structure, biology and structure-based therapeutic development // Acta Pharmacol Sin. 2017. Vol. 38. P. 1205–1235. doi: 10.1038/aps.2017.28</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Perez Ortiz JM, Swerdlow RH. Mitochondrial dysfunction in Alzheimer’s disease: Role in pathogenesis and novel therapeutic opportunities. Br J Pharmacol. 2019;176:3489–3507. doi: 10.1111/bph.14585</mixed-citation><mixed-citation xml:lang="ru">Perez Ortiz J.M., Swerdlow R.H. Mitochondrial dysfunction in Alzheimer’s disease: Role in pathogenesis and novel therapeutic opportunities // Br J Pharmacol. 2019. Vol. 176. P. 3489–3507. doi: 10.1111/bph.14585</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Wang W., Zhao F., Ma X et al. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Mol Neurodegener. 2020;15:30. doi: 10.1186/s13024-020-00376-6</mixed-citation><mixed-citation xml:lang="ru">Wang W., Zhao F., Ma X et al. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances // Mol Neurodegener. 2020. Vol. 15. P. 30. doi: 10.1186/s13024-020-00376-6</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Rao VK, Carlson EA, Yan SS. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Biochim Biophys Acta. 2014;1842:1267–1272. doi: 10.1016/j.bbadis.2013.09.003</mixed-citation><mixed-citation xml:lang="ru">Rao V.K., Carlson E.A., Yan S.S. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration // Biochim Biophys Acta. 2014. Vol. 1842. P. 1267–1272. doi: 10.1016/j.bbadis.2013.09.003</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regener Res. 2013;8:2003–2014. doi: 10.3969/j.issn.1673-5374.2013.21.009</mixed-citation><mixed-citation xml:lang="ru">Guo C., Sun L., Chen X., Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases // Neural Regener Res. 2013. Vol. 8. P. 2003–2014. doi: 10.3969/j.issn.1673-5374.2013.21.009</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Reddy PH, Oliver DM. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer’s disease. Cells. 2019;8:488. doi: 10.3390/cells8050488</mixed-citation><mixed-citation xml:lang="ru">Reddy P.H., Oliver D.M. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer’s disease // Cells. 2019. Vol. 8. P. 488. doi: 10.3390/cells8050488</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Xie C, Aman Y, Adriaanse BA, Cader MZ, Plun-Favreau H, Xiao J, Fang EF. Culprit or bystander: Defective mitophagy in Alzheimer’s disease. Front Cell Dev Biol. 2019;7:391. doi: 10.3389/fcell.2019.00391</mixed-citation><mixed-citation xml:lang="ru">Xie C., Aman Y., Adriaanse B.A., et al. Culprit or bystander: Defective mitophagy in Alzheimer’s disease // Front Cell Dev Biol. 2019. Vol. 7. P. 391. doi: 10.3389/fcell.2019.00391</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221:3–12. doi: 10.1002/path.2697</mixed-citation><mixed-citation xml:lang="ru">Glick D., Barth S., Macleod K.F. Autophagy: Cellular and molecular mechanisms // J Pathol. 2010. Vol. 221. P. 3–12. doi: 10.1002/path.2697</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Wu A-G, Zhou X-G, Qiao G, Yu L, Tang Y, Yan L, Qiu WQ, Pan R, Yu CL, Law BY, Qin DL, Wu JM. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Ageing Res Rev. 2021;65:101202. doi: 10.1016/j.arr.2020.101202</mixed-citation><mixed-citation xml:lang="ru">Wu A.-G., Zhou X.-G., Qiao G., et al. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases // Ageing Res Rev. 2021. Vol. 65. P. 101202. doi: 10.1016/j.arr.2020.101202</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Banati R, Gehrmann J, Kellner M, Holsboer F. Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia. Clin Neuropathol. 1995;14:197–200. PMID: 8521621</mixed-citation><mixed-citation xml:lang="ru">Banati R., Gehrmann J., Kellner M., Holsboer F. Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia // Clin Neuropathol. 1995. Vol. 14. P. 197–200. PMID: 8521621</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Al-Ghraiybah NF, Wang J, Alkhalifa AE, Roberts AB, Raj R, Yang E, Kaddoumi A. Glial cell-mediated neuroinflammation in Alzheimer’s disease. Int J Mol Sci. 2022;23:10572. doi: 10.3390/ijms231810572</mixed-citation><mixed-citation xml:lang="ru">Al-Ghraiybah N.F., Wang J., Alkhalifa A.E., et al. Glial cell-mediated neuroinflammation in Alzheimer’s disease // Int J Mol Sci. 2022. Vol. 23. P. 10572. doi: 10.3390/ijms231810572</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Wu T, Li W-M, Yao Y-M. Interactions between autophagy and inhibitory cytokines. Int J Biol Sci. 2016;12:884–897. doi: 10.7150/ijbs.15194</mixed-citation><mixed-citation xml:lang="ru">Wu T., Li W.-M., Yao Y.-M. Interactions between autophagy and inhibitory cytokines // Int J Biol Sci. 2016. Vol. 12. P. 884–897. doi: 10.7150/ijbs.15194</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">Guo S, Wang H, Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14. doi: 10.3389/fnagi.2022.815347</mixed-citation><mixed-citation xml:lang="ru">Guo S., Wang H., Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases // Front Aging Neurosci. 2022. Vol. 14. doi: 10.3389/fnagi.2022.815347</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Chew G, Petretto E. Transcriptional networks of microglia in Alzheimer’s disease and insights into pathogenesis. Genes (Basel). 2019;10:798. doi: 10.3390/genes10100798</mixed-citation><mixed-citation xml:lang="ru">Chew G., Petretto E. Transcriptional networks of microglia in Alzheimer’s disease and insights into pathogenesis // Genes (Basel). 2019. Vol. 10. P. 798. doi: 10.3390/genes10100798</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Sochocka M, Donskow-Łysoniewska K, Diniz BS, Kurpas D, Brzozowska E, Leszek J. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease — a critical review. Mol Neurobiol. 2019;56:1841–1851. doi: 10.1007/s12035-018-1188-4</mixed-citation><mixed-citation xml:lang="ru">Sochocka M., Donskow-Łysoniewska K., Diniz B.S., et al. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s Disease — a critical review // Mol Neurobiol. 2019. Vol. 56. P. 1841–1851. doi: 10.1007/s12035-018-1188-4</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">Megur A, Baltriukienė D, Bukelskienė V, Burokas A. The microbiota–gut–brain axis and Alzheimer’s disease: Neuroinflammation is to blame? Nutrients. 2020;13:37. doi: 10.3390/nu13010037</mixed-citation><mixed-citation xml:lang="ru">Megur A., Baltriukienė D., Bukelskienė V., Burokas A. The microbiota–gut–brain axis and Alzheimer’s disease: Neuroinflammation is to blame? // Nutrients. 2020. Vol. 13. P. 37. doi: 10.3390/nu13010037</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Bairamian D, Sha S, Rolhion N, Sokol H, Dorothée G, Lemere CA, Krantic S. Microbiota in neuroinflammation and synaptic dysfunction: A focus on Alzheimer’s disease. Mol Neurodegener. 2022;17:19. doi: 10.1186/s13024-022-00522-2</mixed-citation><mixed-citation xml:lang="ru">Bairamian D., Sha S., Rolhion N., et al. Microbiota in neuroinflammation and synaptic dysfunction: A focus on Alzheimer’s disease // Mol Neurodegener. 2022. Vol. 17. P. 19. doi: 10.1186/s13024-022-00522-2</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">Sun Y, Sommerville NR, Liu JYH, Ngan MP, Poon D, Ponomarev ED, Lu Z, Kung JSC, Rudd JA. Intra-gastrointestinal amyloid-β1–42 oligomers perturb enteric function and induce Alzheimer’s disease pathology. J Physiol. 2020;598:4209–4223. doi: 10.1113/JP279919</mixed-citation><mixed-citation xml:lang="ru">Sun Y., Sommerville N.R., Liu J.Y.H., et al. Intra-gastrointestinal amyloid-β1–42 oligomers perturb enteric function and induce Alzheimer’s disease pathology // J Physiol. 2020. Vol. 598. P. 4209–4223. doi: 10.1113/JP279919</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. PLoS Pathog. 2017;13:e1006654. doi: 10.1371/journal.ppat.1006654</mixed-citation><mixed-citation xml:lang="ru">Friedland R.P., Chapman M.R. The role of microbial amyloid in neurodegeneration // PLoS Pathog. 2017. Vol. 13. P. e1006654. doi: 10.1371/journal.ppat.1006654</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">Chen SG, Stribinskis V, Rane MJ, Demuth DR, Gozal E, Roberts AM, Jagadapillai R, Liu R, Choe K, Shivakumar B, Son F, Jin S, Kerber R, Adame A, Masliah E, Friedland RP. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and caenorhabditis elegans. Sci Rep. 2016;6:34477. doi: 10.1038/srep34477</mixed-citation><mixed-citation xml:lang="ru">Chen S.G., Stribinskis V., Rane M.J., et al. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and caenorhabditis elegans // Sci Rep. 2016. Vol. 6. P. 34477. doi: 10.1038/srep34477</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">Mammana S, Fagone P, Cavalli E, Basile MS, Petralia MC, Nicoletti F, Bramanti P, Mazzon E. The role of macrophages in neuroinflammatory and neurodegenerative pathways of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets. Int J Mol Sci. 2018;19(3):831. doi: 10.3390/ijms19030831</mixed-citation><mixed-citation xml:lang="ru">Mammana S., Fagone P., Cavalli E., et al. The role of macrophages in neuroinflammatory and neurodegenerative pathways of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets // Int J Mol Sci. 2018. Vol. 19, N. 3. P. 831. doi: 10.3390/ijms19030831</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE, Dominguez L, Shea JE, Dokholyan NV, De Simone A, Ma B, Nussinov R, Najafi S, Ngo ST, Loquet A, Chiricotto M, Ganguly P, McCarty J, Li MS, Hall C, Derreumaux P. Amyloid oligomers: A joint experimental/computational perspective on Alzheimer’s disease, Parkinson’s disease, type II diabetes, and amyotrophic lateral sclerosis. Chem Rev. 2021;121(4): 2545–2647. doi: 10.1021/acs.chemrev.0c01122</mixed-citation><mixed-citation xml:lang="ru">Nguyen P.H., Ramamoorthy A., Sahoo B.R., et al. Amyloid oligomers: A joint experimental/computational perspective on Alzheimer’s disease, Parkinson’s disease, type II diabetes, and amyotrophic lateral sclerosis // Chem Rev. 2021. Vol. 121, N. 4. P. 2545–2647. doi: 10.1021/acs.chemrev.0c01122</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">Piancone F, Rosa FL, Marventano I, Saresella M, Clerici M. The role of the inflammasome in neurodegenerative diseases. Molecules. 2021;26(4):953. doi: 10.3390/molecules26040953</mixed-citation><mixed-citation xml:lang="ru">Piancone F., Rosa F.L., Marventano I., et al. The role of the inflammasome in neurodegenerative diseases // Molecules. 2021. Vol. 26, N. 4. P. 953. doi: 10.3390/molecules26040953</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: Cellular mechanisms and therapeutic implications. Front Immunol. 2017;8:1005. doi: 10.3389/fimmu.2017.01005</mixed-citation><mixed-citation xml:lang="ru">Liu J., Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: Cellular mechanisms and therapeutic implications // Front Immunol. 2017. Vol. 8. P. 1005. doi: 10.3389/fimmu.2017.01005</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">Chen W, Zhang X, Huang W. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 2016;13(4):3391–3396. doi: 10.3892/mmr.2016.4948</mixed-citation><mixed-citation xml:lang="ru">Chen W., Zhang X., Huang W. Role of neuroinflammation in neurodegenerative diseases (Review) // Mol Med Rep. 2016. Vol. 13, N. 4. P. 3391–3396. doi: 10.3892/mmr.2016.4948</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">Root J, Merino P, Nuckols A, Johnson M, Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;154:105360. doi: 10.1016/j.nbd.2021.105360</mixed-citation><mixed-citation xml:lang="ru">Root J., Merino P., Nuckols A., et al. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis // Neurobiol Dis. 2021. Vol. 154. P. 105360. doi: 10.1016/j.nbd.2021.105360</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">Cai Q, Jeong YY. Mitophagy in Alzheimer's disease and other age-related neurodegenerative diseases. Cells. 2020;9(1):150. doi: 10.3390/cells9010150</mixed-citation><mixed-citation xml:lang="ru">Cai Q., Jeong Y.Y. Mitophagy in Alzheimer's disease and other age-related neurodegenerative diseases // Cells. 2020. Vol. 9. P. 150. doi: 10.3390/cells9010150</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">Evans CS, Holzbaur ELF. Autophagy and mitophagy in ALS. Neurobiol Dis. 2019;122:35–40. doi: 10.1016/j.nbd.2018.07.005</mixed-citation><mixed-citation xml:lang="ru">Evans C.S., Holzbaur E.L.F. Autophagy and mitophagy in ALS // Neurobiol Dis. 2019. Vol. 122. P. 35–40. doi: 10.1016/j.nbd.2018.07.005</mixed-citation></citation-alternatives></ref></ref-list></back></article>
